We urgently need your donations to help us respond.
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
GROW reports and papers
GROW has many partners around the world. Learn more about whom we're working with.